SCHEMBL4307744

SCHEMBL4307744

Nc1cc2nc(-c3ccc(C(=O)O)cc3)oc2cc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.51
▸ SNCA P37840 1/20 0.51
▸ ESR2 Q92731 5/20 0.50
▸ ESR1 P03372 4/20 0.50
▸ TTR P02766 1/20 0.50
▸ ALB P02768 1/20 0.50
▸ MAOA P21397 1/20 0.50
▸ CNR1 P21554 1/20 0.50
▸ DRD1 P21728 1/20 0.50
▸ OPRD1 P41143 1/20 0.50
▸ PDE4D Q08499 1/20 0.50
▸ PDE3A Q14432 1/20 0.50
▸ GPR119 Q8TDV5 1/20 0.49
▸ RAB9A P51151 6/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ TP53 P04637 1/20 0.49
▸ HDAC6 Q9UBN7 5/20 0.46
▸ NPC1 O15118 5/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL17024437 0.99 MAPT (0.50) MAPTSNCAESR2ESR1TTR
SCHEMBL14030787 0.95 MAPT (0.51) MAPTSNCAESR2ESR1TTR
SCHEMBL14030790 0.90 MAPT (0.50) MAPTSNCAESR2ESR1TTR
SCHEMBL14030833 0.86 HDAC6 (0.48) MAPTSNCATTRALBMAOA
SCHEMBL15723573 0.86 MAPT (0.55) MAPTSNCAESR2ESR1RAB9A
SCHEMBL14030812 0.86 GPR119 (0.55) MAPTSNCAESR2ESR1TTR
SCHEMBL14030788 0.86 MAPT (0.52) MAPTSNCAESR2ESR1RAB9A
SCHEMBL13347357 0.86 MAPT (0.59) MAPTSNCAESR2ESR1RAB9A
SCHEMBL9797251 0.85 TTR (0.60) MAPTSNCAESR2ESR1TTR
SCHEMBL14030845 0.85 MAPT (0.50) MAPTSNCAESR2ESR1TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725424-B2 4-(5-amino-6-hydroxybenzoxazol-2-yl) ammonium benzoate and preparation method and use thereof ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2017-08-08 — — US claimed
US-20150239856-A1 4-(5-Amino-6-Hydroxybenzoxazol-2-YL) Ammonium Benzoate and Preparation Method and Use Thereof ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2015-08-27 — — US claimed
US-9725424-B2 4-(5-amino-6-hydroxybenzoxazol-2-yl) ammonium benzoate and preparation method and use thereof ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2017-08-08 — — US disclosed
US-9725424-B2 4-(5-amino-6-hydroxybenzoxazol-2-yl) ammonium benzoate and preparation method and use thereof ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2017-08-08 — — US disclosed
US-9725424-B2 4-(5-amino-6-hydroxybenzoxazol-2-yl) ammonium benzoate and preparation method and use thereof ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2017-08-08 — — US disclosed
US-9725424-B2 4-(5-amino-6-hydroxybenzoxazol-2-yl) ammonium benzoate and preparation method and use thereof ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2017-08-08 — — US disclosed
US-20150239856-A1 4-(5-Amino-6-Hydroxybenzoxazol-2-YL) Ammonium Benzoate and Preparation Method and Use Thereof ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2015-08-27 — — US disclosed
US-20150239856-A1 4-(5-Amino-6-Hydroxybenzoxazol-2-YL) Ammonium Benzoate and Preparation Method and Use Thereof ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2015-08-27 — — US disclosed
US-20150239856-A1 4-(5-Amino-6-Hydroxybenzoxazol-2-YL) Ammonium Benzoate and Preparation Method and Use Thereof ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2015-08-27 — — US disclosed
US-20150239856-A1 4-(5-Amino-6-Hydroxybenzoxazol-2-YL) Ammonium Benzoate and Preparation Method and Use Thereof ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2015-08-27 — — US disclosed
CN-102942533-B Preparation method of 4-(5-amino-6-hydroxy-2-benzoxazolyl) benzoic acid (ABA) YANCHENG DRAGON CHEMICAL CO LTD 2015-01-28 — — CN disclosed
CN-101372532-A Use of 5-amino-6-hydroxy-2-(p-carboxyphenyl)benzoxazole salt UNIV ZHEJIANG TECHNOLOGY (CN) 2009-02-25 — — CN disclosed
US-7495106-B1 O-aminophenol-containing AB-monomer for heterocyclic rigid-rod polymers UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 2009-02-24 — — US disclosed
US-20080269455-A1 Process for Production of Polybenzazole Polymer and the Polymer TOYO BOSEKI KABUSHIKI KAISHA (JP) 2008-10-30 — — US disclosed
US-20080269455-A1 Process for Production of Polybenzazole Polymer and the Polymer TOYO BOSEKI KABUSHIKI KAISHA (JP) 2008-10-30 — — US disclosed
US-20080269455-A1 Process for Production of Polybenzazole Polymer and the Polymer TOYO BOSEKI KABUSHIKI KAISHA (JP) 2008-10-30 — — US disclosed
CN-101016275-A 5-amino-6-hydroxy-2- (p-carboxyphenyl) benzoxazole salt, synthesis and application UNIV ZHEJIANG TECHNOLOGY (CN) 2007-08-15 — — CN disclosed
US-5610261-A COMPRESSIVE STRENGTH, PARA-ORIENTED BENZOXAZOLE CONDENSATION POLYMERS WITH TETRACARBOXY-SUBSTITUTED ADAMANTANE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 1997-03-11 — — US disclosed
US-5426173-A Polybenzoxazoles having improved compressive strength THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 1995-06-20 — — US disclosed
US-5426173-A Polybenzoxazoles having improved compressive strength THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 1995-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239856-A1 4-(5-Amino-6-Hydroxybenzoxazol-2-YL) Ammonium Benzoate and Preparation Method and Use Thereof HAAO, ABAT, HAO2 MAPT 868/4885SNCA 2157/4885ESR2 4189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback